Serial Dilution in 96- & 384-well Microplates
Integra has introduced a Row Dilution Plate Holder accessory for its VIAFLO 96 and 384 handheld benchtop pipettes.
The new row dilution plate holder adds the functionality to perform serial dilutions in rows. Serial dilutions are often carried out in row format because it allows experimenters to dilute more samples (12 instead of 8 in a 96-well plate). The plate holder can easily be adapted to work with either 96 or 384 well plates.
Serial dilution of assay components is a key technique in drug discovery and life science research. In assay development, serial dilution can be used to determine appropriate concentration ranges, in secondary screening to evaluate pharmacological response, and in early ADMET studies to determine toxicological effects. The ability to accurately and reproducibly produce dilution curves is essential to improving assay throughput and quality. Serial dilutions are also regularly used in microbiology when, for instance, initial concentrations of bacteria are orders of magnitude too high to perform a plate count.
The VIAFLO 96/384 offers high sample throughput without a robot. It is a handheld bench top pipette, capable of 96- and 384-well pipetting with a choice of various pipetting heads. The VIAFLO 96 benchtop electronic pipette offers an affordable solution to increase productivity when working with microplates. It closes the gap between traditional manual pipettes and robotic systems, allowing for accurate and reproducible 96-channel pipetting. The VIAFLO 384 is a more advanced system, which can work with both 96- and 384-channel pipetting heads to maximize productivity. It features the same footprint and intuitive user concept as VIAFLO 96.
Related News
-
News Eli Lilly gets ready to launch five new drugs in 2023
Eli Lilly, the American pharmaceutical company (IN, USA) are gearing up for a big year ahead, with hopes to launch five new drugs and capitalise on growing obesity and Alzheimer’s disease markets. -
News Amgen buys Horizon for $27.8 billion in bold step into the rare disease market
Amgen Inc buys pharmaceutical company Horizon Therapeutics in a multibillion-dollar deal, in hopes to capitalise on it's portfolio of drugs in the highly sort after rare disease market. -
News Pharma Supply Chain People Moves
The latest appointments and promotions across the pharmaceutical supply chain. -
News Merck to donate new Ebola vaccine to defend against outbreaks in Uganda
Pharmaceutical giant Merck has announced they will be speeding up the processing of a new vaccine against the latest strain of the Ebola virus, to be donated to a global non-profit organisation for distribution -
News CPHI Podcast Series: Driving innovation with pharmaceutical startups
The latest episode in the CPHI Podcast Series explores how startups are driving innovation by taking high-risk approaches and doing business with greater agility. -
News Greener and efficient processes: Quaternary Ammonium Salts
Quaternary Ammonium Salts play a crucial part in Organic Chemistry processes at many major industries. Discover why.
-
News Biosimilars save patients $11B annually, but barriers to adoption remain in US market
Biosimilars introduce competition into the biologics market, driving down prices and increasing patient access. -
News WHO recommends use of two monoclonal antibody treatments against Ebola
The health body recommended use of treatments by Regeneron and Ridgeback Bio
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance